Total Funding
43
67
Total FundingGrant raised
Growth Score 43 in past quarter
-20 pts
Heat Score 67 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
5715
Lisata Therapeutics is a clinical-stage biopharmaceutical company.
Anne C. Whitaker: Independent DirectorPast Role: Wolfspeed, Director- Kristen K. Buck: Chief Medical Officer
About the Company
Lisata Therapeutics is a clinical-stage pharmaceutical company developing therapies based on clear differentiation and rigorous data applied in areas of high unmet medical need. They focus on the discovery, development, and commercialization of therapies for the treatment of solid tumors and other major diseases.
Women Founded
